Q1:Low transfection efficiency
| Possible reasons | Solution |
Plasmid DNA, siRNA, or transfection reagent was diluted in serum-containing medium or formed complexes in the presence of serum. | Use serum-free medium to dilute plasmid DNA, siRNA, and transfection reagent. |
The dilution time or complex incubation period was too short. | We recommend diluting DNA and transfection reagent separately and incubating for 5 minutes. Then, combine the diluted reagents and incubate for 20 minutes for optimal performance. |
The transfected plasmid DNA or siRNA was degraded or of poor quality. | Ensure that the plasmid DNA or siRNA used for transfection is of high quality. |
There are inhibitors present in the culture medium. | Do not use antibiotics, EDTA, citrate, phosphate, RPMI, chondroitin sulfate, hyaluronic acid, dextran sulfate, or other sulfated proteoglycans in the growth medium or the medium used to prepare the DNA:transfection reagent complex. |
Problems exist in the assay used to measure efficiency or expression. | Use a reporter gene to measure transfection efficiency. |
The cells cannot recognize the promoter/enhancer on the vector. | Verify that the promoter/enhancer on the vector construct is compatible with the target cell type. |
The cells have changed over time, or the splitting conditions have been altered. | If transfection performance suddenly declines, it may be related to the cells. We recommend splitting and plating cells on a consistent schedule and maintaining a cell density that is neither too sparse nor too confluent. Over-passaging can also reduce transfection performance. |
Q2:The cell survival rate is low after transfection.
| Possible reasons | Solution |
| Antimicrobial agents were added to the growth medium during transfection. | Do not use antibiotics such as chloroquine, penicillin, or streptomycin in the growth medium during transfection, as cells become more permeable to antibiotics and may experience increased toxicity. |
| The transfection reagent was stored improperly. | We recommend storing the transfection reagent at 4°C. Freezing or storing at room temperature may reduce its activity. |
| The transfection complexes were not thoroughly mixed in the growth medium. | After adding the transfection complexes to the medium, ensure thorough mixing across the entire plate or well. |
| The cells underwent changes over time, or the splitting conditions were altered. | If transfection efficiency suddenly declines, it may be cell-related. We recommend maintaining a consistent splitting and plating schedule while ensuring cell density is neither too low nor too high. Over-passaging can also impair transfection performance. |
| The cationic lipid reagent was oxidized. | Avoid excessive vortexing or agitation of cationic lipid reagents, as this may promote the formation of lipid peroxides. |
| Selective antibiotics were added too soon after transfection. | When establishing stable cell lines, allow at least 72 hours of resistance gene expression before adding selective antibiotics. |
Q3:The transfection results are not reproducible.
Possible reasons | Solution |
| Over time, the cells may have undergone changes, or the splitting conditions may have been altered. | If transfection efficiency suddenly declines, it may be cell-related. We recommend maintaining a consistent schedule for cell splitting and plating, while keeping cell density neither too sparse nor too confluent. Excessive passaging can also compromise transfection performance. |
| Transfection was performed at varying cell confluencies or different DNA-to-transfection reagent ratios. | Reproducible transfection performance depends on consistent protocols for cell splitting, plating, and transfection (using the same DNA-to-transfection reagent ratio). Variations in DNA preparations or modifications in culture medium may also affect transfection efficiency. |
Kamed Tech is committed to providing professional transfection services to meet our clients' needs in cell biology and molecular biology research. With an experienced team and state-of-the-art facilities, we conduct various types of transfection experiments, including gene delivery, siRNA transfection, miRNA transfection, and CRISPR/Cas9-mediated gene editing.Based on the client's cell type and research objectives, we design and optimize tailored transfection protocols, followed by experimental execution, data analysis, and comprehensive reporting. Whether for fundamental research or drug screening, we deliver high-quality, reliable transfection services to provide critical support for scientific endeavors.
0